Topic
Falsified Medicines
6 published works
BioSlice Blog
Revised guidance on implementation of the EU Falsified Medicines Directive
The Falsified Medicines Directive 2011/62/EU (FMD) introduced a new requirement for safety features to appear on the packaging of all prescription-only medicinal products: a unique product identifier and an anti-tampering…
BioSlice Blog
Amendments to UK Human Medicines Regulations 2012
By Adela Williams, Silvia Valverde
On 18 January, a new statutory instrument, the Human Medicines (Amendment) Regulations 2019 (the Amending Regulations), which amend the Human Medicines Regulations 2012, was laid before Parliament. These regulations will…
BioSlice Blog
Commission Survey on National Penalties for Breach of Falsified Medicines Rules in EU Member States
By Hannah Kerr-Peterson, Ewan Townsend
Article 118a of Directive 2001/83/EC requires Member States to lay down “effective, proportionate and dissuasive” penalties for those who are involved in the manufacturing, distribution, brokering, import and export of…
Focus on Regulation
EC issues a new guidance concerning the safety features for Falsified Medicines
By Elisabethann Wright, Maria Chaita
The European Commission has published a guidance concerning "Safety Features for medicinal products for human use" (Guidance). The Guidance is in the form of a "Questions and Answers" document. It…
BioSlice Blog
Arvato to implement UK falsified medicines verification system
One of the obligations imposed on Member States under the Falsified Medicines Directive 2011/62/EU (FMD) is to put in place a medicines verification system by 9 February 2019. In the…
Focus on Regulation
Notification of draft Commission Delegated Regulation on the Implementation of Obligatory Safety Features for Medicinal Products
By Elisabethann Wright, Helen Kerr
On 12 August 2015, the European Commission notified the World Trade Organisation ("WTO") of its draft Delegated Regulation supplementing Directive 2001/83/EC of the European Parliament and of the Council by…